E. Rousseau et al., BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF CYCLIC-NUCLEOTIDEPHOSPHODIESTERASE IN AIRWAY EPITHELIUM, Molecular and cellular biochemistry, 140(2), 1994, pp. 171-175
According to their respective elution order, specificity for cAMP and
cGMP, their sensitivity to calmodulin, and their modulation by cGMP an
d rolipram, four cyclic nucleotide phosphodiesterases (PDE) were separ
ated from the cytosol: PDE I (calmodulin-sensitive), PDE II (stimulate
d by cGMP, PDE IV (cGMP specific-PDE and inhibited by rolipram) and PD
E V (cGMP specific). PDE IV (K-m = 1.4 mu M) was competitively inhibit
ed by rolipram (K-i = 1.2 mu M) whereas PDE V (K-m = 0.83 mu M) was co
mpetitively inhibited by zaprinast in the mu molar range (K-i = 0.12 m
u M). Moreover the microsomal fraction contained three PDE isoforms: P
DE II, PDE III (inhibited by cGMP or indolidan) and PDE IV. These resu
lts show that cAMP degradation in cytosolic and membrane fractions is
modulated by cGMP and selectively inhibited by rolipram and, in additi
on, by indolidan in membrane fractions.